Akaboshi I, Endo F, Matsuda I, Saheki T
J Inherit Metab Dis. 1983;6(1):36-9. doi: 10.1007/BF02391191.
Argininosuccinate (ASA) synthetase in the liver from a patient with a variant form of citrullinaemia was analysed. Serum citrulline level was approximately 40 times higher than the control level, and the ASA synthetase activity was approximately 10% that of the control. Other urea cycle enzymes were within normal ranges. The specific activity (enzyme activity/enzyme protein, measured by immunochemical method), pH optimum, Michaelis constants, and thermal denaturation in the presence or absence of ASA were similar to those in enzymes obtained from the normal and the patient's liver cells. No in vitro effect of the patient's liver homogenate on ASA synthetase in normal liver was observed. Serum citrulline levels of the patient's parents and young brother were at the maximal level of control at fasting and definitely elevated 4 h after citrulline loading (100 mg/kg).
对一名患有变异型瓜氨酸血症患者肝脏中的精氨琥珀酸(ASA)合成酶进行了分析。患者血清瓜氨酸水平约比对照水平高40倍,而ASA合成酶活性约为对照的10%。其他尿素循环酶活性在正常范围内。其比活性(通过免疫化学方法测定的酶活性/酶蛋白)、最适pH值、米氏常数以及在有无ASA存在时的热变性情况,均与从正常及患者肝细胞中获得的酶相似。未观察到患者肝脏匀浆对正常肝脏中ASA合成酶的体外作用。该患者父母及幼弟的血清瓜氨酸水平在空腹时处于对照的最高水平,在给予瓜氨酸负荷(100mg/kg)4小时后明显升高。